Key Takeaways Phibro's Animal Health unit grew 42% with a standout 68% rise in MFAs and other product sales in fiscal Q3. Phibro saw 40% of fiscal Q3 revenues from international markets like Latin America, India and Southeast Asia. PAHC's Mineral Nutrition and Performance Products units posted double-digit sales growth recovery.Phibro Animal Health Corporation’s (PAHC) focus on advancing its Animal Health business is poised to drive growth in the upcoming quarters. The company’s global growth prospects lo ...

Key Takeaways TotalEnergies secured the 1 GW N-9.4 offshore wind concession in the North Sea for a 25-year term. TTE aims to cut costs by developing N-9.4 alongside nearby N-9.1 and N-9.2 sites with RWE. TTE will pay $20.7M to Germany for marine efforts and $9.3M annually to the grid operator for 20 years.TotalEnergies SE (TTE) announced that it has been awarded the N-9.4 offshore concession by the Federal Network Agency. TTE is a shareholder of North Sea OFW One GmbH. The primary benefit of offshore wind ...

Key Takeaways Micron Technology, Inc. (MU) has delivered a solid 17.8% gain over the past three months. This performance easily beats the broader Zacks Computer and Technology sector, which rose 12% in the same period. Micron stock has also moved ahead of several chip peers, including Marvell Technology, Inc. (MRVL) , QUALCOMM Incorporated (QCOM) and Intel Corporation (INTC) . While shares of Marvell Technology have risen 0.2% over the past three months, QUALCOMM and Intel have declined 2.4% and 13.8%, resp ...

Euroseas Ltd. (ESEA) came out with quarterly earnings of $3.76 per share, beating the Zacks Consensus Estimate of $3.35 per share. This compares to earnings of $2.66 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 12.24%. A quarter ago, it was expected that this company would post earnings of $3.66 per share when it actually produced earnings of $3.33, delivering a surprise of -9.02%. Over the last four quarters, the company ...

On this news, Dyne's stock price fell $2.96 per share, or 21.42%, to close at $10.86 per share on June 17, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz conti ...

Top national builder now selling at Newport Pointe in Discovery Bay and Malana at Lakeview in Mountain HouseSACRAMENTO, Calif., June 18, 2025 /PRNewswire/ -- Century Communities, Inc. (NYSE: CCS)—a top national homebuilder, industry leader in online home sales, and featured on America's Most Trustworthy Companies and World's Most Trustworthy Companies by Newsweek—announced that the company will host two Grand Opening celebrations on June 21 for Newport Pointe (now selling in Discovery Bay) and Malana at Lak ...

Key Takeaways WidePoint is positioned to benefit from rising federal IT spending and growing contract momentum. WYY gained FedRAMP authorization and is progressing under DoD's Spiral 4 and DHS' CWMS 3.0 efforts. With a recent stock drop, WYY trades at a low 0.18X P/S ratio, far below the 1.81X industry average.WidePoint Corporation (WYY) appears well-positioned to benefit from rising federal IT spending, particularly through its strategic alignment with key government priorities and growing contract momen ...

Applied Materials, Inc. (NASDAQ: AMAT ) shows a very common picture in 2025. Strong, profitable businesses with very rich valuations. Until the market decides to care, the stocks can stay elevated. And, dips will be bought. Based on the many market cyclesI'm Rob Isbitts, founder of Sungarden Investment Publishing. I run the new investing group Sungarden Investors Club, a community dedicated to navigating the modern investment climate with humility, discipline, and a non-traditional approach to income invest ...

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS ) is a biotechnology company with three commercial products generating sales and proprietary formulation modification technologies. I recommend that investors monitor this company as its revenue is accelerating thanks to the sales ofAnalyst’s Disclosure:I/we have a beneficial long position in the shares of XERS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensat ...

Key Takeaways Boston Scientific's Neuromodulation segment posted 6.8% operational sales growth in Q1 2025. BSX saw strong gains from Intracept, Cartesia leads, and Lumina 3D within pain and brain therapies. Boston Scientific expects continued growth in 2025, aided by Relievant and Axonics acquisitions.Boston Scientific’s (BSX) Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. This segment reflects the company’s long-term co ...